EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Thrombocytopenia after Hematopoietic Stem Cell Transplantation in Pediatrics and Adults: A Narrative Review Including Etiology, Management, Monitoring, and Novel Therapies

Amirali Kalantari iD, Zahra Karimizadeh iD, Leila Jafari, Maryam Behfar, Amir Ali Hamidieh iD

Seminars in Thrombosis and Hemostasis · 01.02.2026 · 52 (01) · 106-125

DOI: 10.1055/a-2673-4266 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Thrombosis and Hemostasis, erschienen am 01.02.2026. Verfasst von Amirali Kalantari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Cell and Gene Therapy Research Center, Gene, Cell and Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Thrombocytopenia. Die Arbeit nennt 221 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thrombocytopenia following hematopoietic stem cell transplantation (HSCT) is a common complication that is associated with a remarkable increase in morbidity and mortality. Post-HSCT thrombocytopenia is a multifactorial condition with several mechanisms, including reduced platelet production in bone marrow, immune-mediated platelet destruction, and consumptive thrombocytopenia. Graft-versus-host disease (GVHD), medications, infections, and autoimmune mechanisms are potential risk factors for post-HSCT thrombocytopenia. Management of post-HSCT thrombocytopenia primarily focuses on supportive care through platelet transfusions. Moreover, immunosuppressive agents are used to target immune-mediated mechanisms. Thrombopoietin receptor agonists and complement inhibitors are novel treatment options with promising results and fewer side effects. However, further research is essential to establish treatment protocols and improve patient care. In this review, we provide a better understanding of the pathophysiology and risk factors associated with post-HSCT thrombocytopenia for early detection and intervention, ultimately aiming to reduce complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationThrombocytopeniaHumansAdultChildRisk Factors

Autor:innen und Institutionen

  • Pediatric Cell and Gene Therapy Research Center, Gene, Cell and Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Amirali Kalantari, Zahra Karimizadeh, Amir Ali Hamidieh

Zitieren

APA

Kalantari, A., Karimizadeh, Z., Jafari, L., Behfar, M., & Hamidieh, A. A. (2026). Thrombocytopenia after Hematopoietic Stem Cell Transplantation in Pediatrics and Adults: A Narrative Review Including Etiology, Management, Monitoring, and Novel Therapies. Seminars in Thrombosis and Hemostasis, 52(01), 106-125. https://doi.org/10.1055/a-2673-4266

Vancouver

Kalantari A, Karimizadeh Z, Jafari L, Behfar M, Hamidieh AA. Thrombocytopenia after Hematopoietic Stem Cell Transplantation in Pediatrics and Adults: A Narrative Review Including Etiology, Management, Monitoring, and Novel Therapies. Seminars in Thrombosis and Hemostasis. 2026;52(01):106-125. doi:10.1055/a-2673-4266

BibTeX
@article{Kalantari2026,
  author = {Kalantari, Amirali and Karimizadeh, Zahra and Jafari, Leila and Behfar, Maryam and Hamidieh, Amir Ali},
  title = {Thrombocytopenia after Hematopoietic Stem Cell Transplantation in Pediatrics and Adults: A Narrative Review Including Etiology, Management, Monitoring, and Novel Therapies},
  journal = {Seminars in Thrombosis and Hemostasis},
  year = {2026},
  volume = {52},
  number = {01},
  pages = {106--125},
  doi = {10.1055/a-2673-4266}
}
Kostenlos starten →